Apple Watch gets revamped blood oxygen feature
Software updates will add the capability to an array of Series 9, Series 10, and Ultra 2 Apple Watch models, according to the iPhone maker.
'This update was enabled by a recent US Customs ruling,' Apple said in a blog post.
Apple temporarily halted US sales of its latest smartwatch models last January as part of a patent feud with health company Masimo.
Masimo, based in southern California, filed a complaint to the US International Trade Commission (ITC) which decided to halt imports of the Apple Watch models over a patented technology for detecting blood-oxygen levels.
Apple manufactures the vast majority of its products overseas, giving the ITC jurisdiction over the patent feud.
BT in your inbox
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
Sign Up
Sign Up
According to reports, Apple removed the technology from the smartwatches in question at the time and resumed selling them.
Masimo argued that it invented the technology and that Apple poached key employees to win access to the know-how.
But Apple contended that the ITC finding was in error and appealed the decision in US federal court.
Apple strongly promotes its smartwatch's fitness and health features, which include detection of heartbeat irregularities, falls, sleep apnea and harmful noise levels. AFP
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Times
3 hours ago
- Business Times
Buffett buys US$1.6 billion UnitedHealth stake, sells T-Mobile
[NEW YORK] Warren Buffett's Berkshire Hathaway bought shares of UnitedHealth Group in the second quarter, sending the health insurer's stock soaring in post-market trading. The chief executive officer of the Omaha, Nebraska-based conglomerate acquired five million shares in UnitedHealth, granting Berkshire a stake worth US$1.6 billion, according to a filing on Thursday (Aug 14). Berkshire also sold its US$1 billion stake in T-Mobile US during the period, exiting the telecommunications operator. Buffett's investment in UnitedHealth comes as the health company faces multiple crises. Last year, a UnitedHealth executive, Brian Thompson, was shot to death in Manhattan. UnitedHealth, along with other US health insurers, has also faced unexpected increases in medical costs. In April, it reported earnings below Wall Street estimates for the first time in more than a decade, sending the stock price plummeting. It has since replaced its CEO and announced plans to replace its chief financial officer. The disclosure of Berkshire's UnitedHealth stake pushed the insurer's shares up as much as 9.6 per cent in post-market trading on Thursday. Apple, BOA trim Buffett also sold 20 million shares of Apple during the period, after slashing his holding in the iPhone manufacturer last year. Berkshire's Apple stake remains its largest equity stake by market value, despite it falling by about US$9.2 billion in the three months ended Jun 30. Berkshire also renewed its effort to trim its holding in Bank of America (BOA), selling 26 million shares and bringing its stake down to about 8 per cent at the end of June. Buffett started whittling down the bank investment last year, without providing any explanation for the move. One of its equity bets, a stake in consumer foods giant Kraft Heinz, has been a headache for Buffett's company. The conglomerate took a US$3.8 billion impairment charge on its investment earlier this year, and kept its holding unchanged in the second quarter. Meanwhile, Berkshire tweaked its investment in US homebuilders, building its stake in Lennar and selling shares of DR Horton. The company also bought more shares of steel manufacturer Nucor. Those changes were omitted in a previous filing as the company requested confidentiality treatment from the Securities and Exchange Commission. BLOOMBERG
Business Times
5 hours ago
- Business Times
Apple rejects Musk claim of App Store bias
APPLE on Thursday rejected Elon Musk's claim that its digital App Store favours OpenAI's ChatGPT over his company's Grok and other rival AI assistants. Musk has accused Apple of giving unfair preference to ChatGPT on its App Store and threatened legal action, triggering a fiery exchange with OpenAI CEO Sam Altman this week. 'The App Store is designed to be fair and free of bias,' Apple said in reply to an AFP inquiry. 'We feature thousands of apps through charts, algorithmic recommendations, and curated lists selected by experts using objective criteria.' Apple added that its goal at the App Store is to offer 'safe discovery' for users and opportunities for developers to get their creations noticed. But earlier this week, Musk said Apple was 'behaving in a manner that makes it impossible for any AI company besides OpenAI to reach #1 in the App Store, which is an unequivocal antitrust violation,' without providing evidence to back his claim. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up 'xAI will take immediate legal action,' he said on his social media network X, referring to his own artificial intelligence company, which is responsible for Grok. X users responded by pointing out that China's DeepSeek AI hit the top spot in the App Store early this year, and Perplexity AI recently ranked number one in the App Store in India. DeepSeek and Perplexity compete with OpenAI and Musk's startup xAI. Altman called Musk's accusation 'remarkable' in a response on X, charging that Musk himself is said to 'manipulate X to benefit himself and his own companies and harm his competitors and people he doesn't like.' Musk called Altman a 'liar' in the heated exchange. OpenAI and xAI recently released new versions of ChatGPT and Grok. App Store rankings listed ChatGPT as the top free app for iPhones on Thursday, with Grok in seventh place. Factors going into App Store rankings include user engagement, reviews and the number of downloads. Grok was temporarily suspended on Monday in the latest controversy surrounding the chatbot. No official explanation was provided for the suspension, which followed multiple accusations of misinformation including the bot's misidentification of war-related images -- such as a false claim that an AFP photo of a starving child in Gaza was taken in Yemen years earlier. Last month, Grok triggered an online storm after inserting antisemitic comments into answers without prompting. In a statement on Grok's X account later that month, the company apologised 'for the horrific behaviour that many experienced.' A US judge has cleared the way for a trial to consider OpenAI legal claims accusing Musk - a co-founder of the company - of waging a 'relentless campaign' to damage the organisation after it achieved success following his departure. The litigation is another round in a bitter feud between the generative AI start-up and the world's richest person. Musk founded xAI in 2023 to compete with OpenAI and the other major AI players. AFP
Business Times
5 hours ago
- Business Times
Apple Watch gets revamped blood oxygen feature
APPLE on Thursday said some of its top smartwatch models are getting a redesigned blood oxygen sensing feature, sidelined for several years by a patent dispute. Software updates will add the capability to an array of Series 9, Series 10, and Ultra 2 Apple Watch models, according to the iPhone maker. 'This update was enabled by a recent US Customs ruling,' Apple said in a blog post. Apple temporarily halted US sales of its latest smartwatch models last January as part of a patent feud with health company Masimo. Masimo, based in southern California, filed a complaint to the US International Trade Commission (ITC) which decided to halt imports of the Apple Watch models over a patented technology for detecting blood-oxygen levels. Apple manufactures the vast majority of its products overseas, giving the ITC jurisdiction over the patent feud. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up According to reports, Apple removed the technology from the smartwatches in question at the time and resumed selling them. Masimo argued that it invented the technology and that Apple poached key employees to win access to the know-how. But Apple contended that the ITC finding was in error and appealed the decision in US federal court. Apple strongly promotes its smartwatch's fitness and health features, which include detection of heartbeat irregularities, falls, sleep apnea and harmful noise levels. AFP
